Every participant also received daily oral doses of calcium and 400IUs of vitamin D. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug.
Svaki participant je još dobijao dnevne oralne doze od 500 mg kalcijuma i 400 IUs vitamina D. Na kraju studije ustanovljeno je da su obe doze značajno smanjile rizik pojave novih kičmenih fraktura, za 50-52%, u poređenju sa efektom placebo leka.